文献速递睡眠呼吸障碍小儿耳鼻咽喉

腺样体扁桃体切除术与轻度阻塞性睡眠呼吸障碍儿童血压:PATS随机临床试验的探索性分析

Adenotonsillectomy and Blood Pressure in Children With Mild Obstructive Sleep-Disordered Breathing: An Exploratory Analysis of the PATS Randomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2025-01-01

本研究为PATS随机临床试验的次要结局探索性分析,纳入458例3至12.9岁打鼾伴轻度阻塞性睡眠呼吸障碍患儿,随机分入早期腺样体扁桃体切除术组(eAT)与观察等待支持治疗组(WWSC),随访12个月。结果显示eAT组收缩压与舒张压百分位下降而WWSC组上升,组间变化差异分别为-9.02(95%CI,-14.77至-3.28)与-6.53(95%CI,-11.02至-2.03);超重/肥胖儿童从eAT中获益更多。

要点

  • eAT组12个月内收缩压和舒张压百分位下降,WWSC组则上升。
  • 收缩压变化组间差异-9.02(95%CI,-14.77至-3.28),舒张压为-6.53(95%CI,-11.02至-2.03)。
  • 体重指数高于第85百分位的儿童,eAT对舒张压的效应更大,交互效应估计值为-10.40(95%CI,-19.69至-1.12;P=0.03)。

核心结论

  • 在这项PATS随机临床试验的探索性分析中,血压轨迹因治疗组别而异,eAT导致收缩压和舒张压百分位下降而WWSC导致上升,超重/肥胖儿童较非超重/肥胖儿童从eAT中获益更多。

研究设计与样本

  • PATS随机临床试验的次要结局探索性分析,在美国7家三级儿科中心开展,参与者招募时间为2016年6月29日至2021年2月1日,数据分析时间为2024年7月至11月。
  • 纳入3至12.9岁、打鼾且轻度阻塞性睡眠呼吸障碍(阻塞性呼吸暂停低通气指数<3,伴扁桃体肥大[Brodsky分级≥2级])的儿童,随机分为eAT组与WWSC组,随访12个月。
  • 分析纳入458例参与者,平均(SD)年龄6.1(2.3)岁,230例(50.2%)为女性,169例(36.9%)有超重/肥胖,231例(50.4%)接受eAT。

主要发现

  • 基线平均(SD)收缩压百分位为60.62(25.22),舒张压百分位为53.86(21.05)。
  • 从基线至12个月,eAT组收缩压和舒张压下降,而WWSC组上升。
  • 收缩压从基线变化值的组间差异为-9.02(95%CI,-14.77至-3.28),舒张压为-6.53(95%CI,-11.02至-2.03)。
  • 调节分析显示,体重指数高于第85百分位的儿童中eAT对舒张压的效应更大,交互效应估计值为-10.40(95%CI,-19.69至-1.12;P=0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The impact of adenotonsillectomy on blood pressure (BP) in children with mild obstructive sleep-disordered breathing (oSDB) remains unclear. OBJECTIVE: To compare BP trajectories in children with mild oSDB randomized to early adenotonsillectomy (eAT) vs watchful waiting with supportive care (WWSC). DESIGN, SETTING, AND PARTICIPANTS: This was a secondary outcome exploratory analysis of the Pediatric Adenotonsillectomy Trial for Snoring (PATS), a randomized clinical trial where children aged 3 to 12.9 years with snoring and mild oSDB (Obstructive Apnea-Hypopnea Index <3 with tonsillar hypertrophy [Brodsky scale grade ≥2]) were randomized to eAT vs WWSC and followed up for 12 months. PATS was conducted across 7 tertiary pediatric centers in the US. Participants were recruited from June 29, 2016, to February 1, 2021. Data were analyzed between July and November 2024. INTERVENTIONS: eAT vs WWSC. MAIN OUTCOMES AND MEASURES: The outcomes of interest were 12-month changes in BP percentiles from baseline and the moderating effect of covariates on these changes. BP was measured with an automated oscillometric BP device at baseline, 6 months, and 12 months after randomization. The treatment effect on BP trajectories was evaluated using mixed-effect models. RESULTS: Of 458 participants included in the analysis, the mean (SD) age was 6.1 (2.3) years, 230 (50.2%) were female, and 169 (36.9%) had overweight/obesity. Mean (SD) baseline systolic BP (SBP) and diastolic BP (DBP) percentiles were 60.62 (25.22) and 53.86 (21.05), respectively, and 231 participants (50.4%) underwent eAT. From baseline to 12 months, SBP and DBP decreased in the eAT group but increased in the WWSC group. The between-group difference in changes from baseline for SBP was -9.02 (95% CI, -14.77 to -3.28) and for DBP was -6.53 (95% CI, -11.02 to -2.03). Moderation analysis showed that the effect of eAT on DBP was greater among children with body mass index higher than the 85th percentile, with an interaction effect estimate of -10.40 (95% CI, -19.69 to -1.12; P = .03). CONCLUSION AND RELEVANCE: In this exploratory analysis of the PATS randomized clinical trial, BP trajectories differed by treatment arm. eAT led to decreases in SBP and DBP percentiles, while WWSC led to increases. Children with overweight/obesity benefited more from eAT than children without. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02562040.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Cabrera AJ, Li D, Redline S, et al. Adenotonsillectomy and Blood Pressure in Children With Mild Obstructive Sleep-Disordered Breathing: An Exploratory Analysis of the PATS Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40875240. doi:10.1001/jamaoto.2025.2555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。